CORC  > 山东大学
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia
Huang, Xinfang; Du, Hui; Gu, Jieruo; Zhao, Dongbao; Jiang, Lindi; Li, Xinfu; Zuo, Xiaoxia; Liu, Yi; Li, Zhanguo; Li, Xiangpei
刊名International journal of rheumatic diseases
2014
卷号17期号:6页码:679-686
关键词allopurinol febuxostat gout hyperuricemia
DOI10.1111/1756-185X.12266
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4796379
专题山东大学
作者单位1.Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai 200001, Peoples R China
2.Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, S
推荐引用方式
GB/T 7714
Huang, Xinfang,Du, Hui,Gu, Jieruo,et al. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia[J]. International journal of rheumatic diseases,2014,17(6):679-686.
APA Huang, Xinfang.,Du, Hui.,Gu, Jieruo.,Zhao, Dongbao.,Jiang, Lindi.,...&L.(2014).An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.International journal of rheumatic diseases,17(6),679-686.
MLA Huang, Xinfang,et al."An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia".International journal of rheumatic diseases 17.6(2014):679-686.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace